Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Phase II Fail Prompts Acceleron to Discontinue Development of Renal Cell Carcinoma Drug
Phase II Fail Prompts Acceleron to Discontinue Development of Renal Cell Carcinoma Drug
Phase II Fail Prompts Acceleron to Discontinue Development of Renal Cell Carcinoma Drug
Submitted by
admin
on June 15, 2017 - 9:39am
Source:
Xtalks
News Tags:
Acceleron
renal cell carcinoma
clinical trials
Axitinib
Headline:
Phase II Fail Prompts Acceleron to Discontinue Development of Renal Cell Carcinoma Drug
Do Not Allow Advertisers to Use My Personal information
